154 related articles for article (PubMed ID: 3291447)
1. The main obstacle to a malaria vaccine: the malaria parasite.
Miller LH; Good MF
Vaccine; 1988 Apr; 6(2):104-6. PubMed ID: 3291447
[TBL] [Abstract][Full Text] [Related]
2. Development of a sporozoite malaria vaccine.
Nussenzweig V; Nussenzweig RS
Am J Trop Med Hyg; 1986 Jul; 35(4):678-88. PubMed ID: 2425647
[No Abstract] [Full Text] [Related]
3. The malaria sporozoite vaccine: parasitology's brave new world.
Spriggs DR
J Infect Dis; 1985 Sep; 152(3):655-6. PubMed ID: 2411830
[No Abstract] [Full Text] [Related]
4. T-cell epitopes in Pf155/RESA, a major candidate for a Plasmodium falciparum malaria vaccine.
Kabilan L; Troye-Blomberg M; Perlmann H; Andersson G; Högh B; Petersen E; Björkman A; Perlmann P
Proc Natl Acad Sci U S A; 1988 Aug; 85(15):5659-63. PubMed ID: 2456577
[TBL] [Abstract][Full Text] [Related]
5. Human T-cell recognition of the circumsporozoite protein of Plasmodium falciparum: immunodominant T-cell domains map to the polymorphic regions of the molecule.
Good MF; Pombo D; Quakyi IA; Riley EM; Houghten RA; Menon A; Alling DW; Berzofsky JA; Miller LH
Proc Natl Acad Sci U S A; 1988 Feb; 85(4):1199-203. PubMed ID: 2448793
[TBL] [Abstract][Full Text] [Related]
6. Expression of Plasmodium falciparum circumsporozoite proteins in Escherichia coli for potential use in a human malaria vaccine.
Young JF; Hockmeyer WT; Gross M; Ballou WR; Wirtz RA; Trosper JH; Beaudoin RL; Hollingdale MR; Miller LH; Diggs CL
Science; 1985 May; 228(4702):958-62. PubMed ID: 2988125
[TBL] [Abstract][Full Text] [Related]
7. [Malaria vaccine research].
Sellioğlu B
Mikrobiyol Bul; 1986 Jan; 20(1):37-41. PubMed ID: 3523172
[TBL] [Abstract][Full Text] [Related]
8. The circumsporozoite protein gene from NF54, a Plasmodium falciparum isolate used in malaria vaccine trials.
Caspers P; Gentz R; Matile H; Pink JR; Sinigaglia F
Mol Biochem Parasitol; 1989 Jun; 35(2):185-9. PubMed ID: 2671723
[No Abstract] [Full Text] [Related]
9. Sporozoite malaria vaccine. Where do we stand?
Nussenzweig V; Nussenzweig S
Ann Parasitol Hum Comp; 1990; 65 Suppl 1():49-52. PubMed ID: 1702271
[TBL] [Abstract][Full Text] [Related]
10. Minimal variation in a vaccine candidate from the sexual stage of Plasmodium falciparum.
Kaslow DC; Quakyi IA; Keister DB
Mol Biochem Parasitol; 1989 Jan; 32(1):101-3. PubMed ID: 2643034
[No Abstract] [Full Text] [Related]
11. Lack of cross-reactivity between variant T cell determinants from malaria circumsporozoite protein.
de la Cruz VF; Maloy WL; Miller LH; Lal AA; Good MF; McCutchan TF
J Immunol; 1988 Oct; 141(7):2456-60. PubMed ID: 2459211
[TBL] [Abstract][Full Text] [Related]
12. Recent efforts in the development of a sporozoite vaccine against human malaria.
Hockmeyer WT; Dame JB
Adv Exp Med Biol; 1985; 185():233-45. PubMed ID: 3907309
[TBL] [Abstract][Full Text] [Related]
13. Epitopes recognized by human T lymphocytes on malaria circumsporozoite protein.
Sinigaglia F; Guttinger M; Gillessen D; Doran DM; Takacs B; Matile H; Trzeciak A; Pink JR
Eur J Immunol; 1988 Apr; 18(4):633-6. PubMed ID: 2452748
[TBL] [Abstract][Full Text] [Related]
14. Potential vaccine antigens of the asexual blood-stages of Plasmodium falciparum.
Anders RF; Brown GV; Coppel RL; Stahl HD; Bianco AE; Favaloro JM; Crewther PE; Culvenor JG; Kemp DJ
Dev Biol Stand; 1985; 62():81-9. PubMed ID: 2422079
[TBL] [Abstract][Full Text] [Related]
15. Towards a malaria vaccine: what is in sight?
del Giudice G
Allergol Immunopathol (Madr); 1991; 19(3):129-35. PubMed ID: 1799171
[No Abstract] [Full Text] [Related]
16. The circumsporozoite protein of Plasmodium: a mechanism of immune evasion by the malaria parasite?
Schofield L
Bull World Health Organ; 1990; 68 Suppl(Suppl):66-73. PubMed ID: 1709835
[TBL] [Abstract][Full Text] [Related]
17. Evidence for a 6.5-day minimum exoerythrocytic cycle for Plasmodium falciparum in humans and confirmation that immunization with a synthetic peptide representative of a region of the circumsporozoite protein retards infection.
Murphy JR; Baqar S; Davis JR; Herrington DA; Clyde DF
J Clin Microbiol; 1989 Jul; 27(7):1434-7. PubMed ID: 2671011
[TBL] [Abstract][Full Text] [Related]
18. Immunization trials with the ring-infected erythrocyte surface antigen of Plasmodium falciparum in owl monkeys (Aotus vociferans).
Collins WE; Pappaioanou M; Anders RF; Campbell GH; Brown GV; Kemp DJ; Broderson JR; Coppel RL; Skinner JC; Procell PM
Am J Trop Med Hyg; 1988 Mar; 38(2):268-82. PubMed ID: 3281493
[TBL] [Abstract][Full Text] [Related]
19. Antigenic polymorphism in malaria: is it an important mechanism for immune evasion?
Mendis KN; David PH; Carter R
Immunol Today; 1991 Mar; 12(3):A34-7. PubMed ID: 2069676
[TBL] [Abstract][Full Text] [Related]
20. The T cell response to the malaria circumsporozoite protein: an immunological approach to vaccine development.
Good MF; Berzofsky JA; Miller LH
Annu Rev Immunol; 1988; 6():663-88. PubMed ID: 2968085
[No Abstract] [Full Text] [Related]
[Next] [New Search]
